Provider of treatment services of cancer and auto-immune diseases. The company develops immuno-oncology monoclonal antibodies, antibody drug conjugates, bispecific antibodies and immunotherapies for the treatment of cancer and associated pain.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore NantiBody‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.